• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocular Therapeut (NQ: OCUL )

10.86 -0.22 (-2.03%)
Streaming Delayed Price Updated: 9:54 AM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,153
Open 10.93
Bid (Size) 10.84 (1)
Ask (Size) 10.87 (1)
Prev. Close 11.08
Today's Range 10.78 - 10.99
52wk Range 1.995 - 11.78
Shares Outstanding 155,921,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Biotech Stocks to Sell in August Before They Crash & Burn
August 06, 2024
Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains. 
Via InvestorPlace
Beyond The Numbers: 8 Analysts Discuss Ocular Therapeutix Stock
August 01, 2024
Via Benzinga

Performance

YTD
+125.68%
+125.68%
1 Month
+24.77%
+24.77%
3 Month
+28.31%
+28.31%
6 Month
+116.24%
+116.24%
1 Year
+280.88%
+280.88%

More News

Read More
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via Benzinga
Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
June 14, 2024
Via Benzinga
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
April 16, 2024
Via Benzinga
Decoding 6 Analyst Evaluations For Ocular Therapeutix
March 13, 2024
Via Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
June 20, 2024
Via Benzinga
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
June 20, 2024
Via Benzinga
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
June 20, 2024
Via Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via Benzinga
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
June 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 28, 2024
Via Benzinga
OCUL Stock Earnings: Ocular Therapeutix Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via Benzinga
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
May 06, 2024
Via Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
Via The Motley Fool
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 19, 2024
Via Benzinga
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
April 18, 2024
Via Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
Via Benzinga
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
April 16, 2024
Via InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
Via InvestorPlace
Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential
April 01, 2024
Via InvestorPlace
These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results
March 12, 2024
Via Benzinga
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
March 12, 2024
Via Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap